Current News

Contact | Print version | PDF version | Send article | RSS feed

Capsulution Nanoscience AG - Further Fundamental Patent Grant is Imminent

30 Nov 2005 - Following a recent notice from the European Patent Office, Capsulution Nanoscience AG announced that a further fundamental patent grant for its nano- and microencapsulation technology - known as the LBL-Technology® - is imminent.
 
The patent with the number EP 1064087 covers the manufacture of multifunctional nano- and micron-sized capsules. The tiny capsules can be filled with pharmaceutical drug compounds as well as with other active substances. On the basis of the LBL-Technology® Capsulution develops advanced drug delivery systems, which bring drugs more safely and effectively to the right site of the body.
 
The LBL-Technology® represents a versatile encapsulation system. For the actual encapsulation, a wide range of FDA-approved polymers can be used. In addition, the capsules' surface can be functionalized to suit a targeted release in the human body.